Assenagon Asset Management

Assenagon Asset Management Portfolio holdings

AUM $62.6B
1-Year Est. Return 28.34%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+28.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$66.6B
AUM Growth
-$1.07B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
1,251
New
Increased
Reduced
Closed

Top Buys

1
+$970M
2
+$687M
3
+$635M
4
PDD icon
Pinduoduo
PDD
+$630M
5
MELI icon
Mercado Libre
MELI
+$623M

Top Sells

1
+$887M
2
+$715M
3
+$607M
4
TSLA icon
Tesla
TSLA
+$477M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$470M

Sector Composition

1 Technology 40.31%
2 Consumer Discretionary 16.15%
3 Healthcare 11.34%
4 Communication Services 8.29%
5 Financials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1101
PMV Pharmaceuticals
PMVP
$76.8M
$176K ﹤0.01%
140,468
+17,376
INNV icon
1102
InnovAge Holding
INNV
$1.04B
$170K ﹤0.01%
+32,676
ARAY icon
1103
Accuray
ARAY
$54.4M
$169K ﹤0.01%
205,228
-288,499
FATE icon
1104
Fate Therapeutics
FATE
$153M
$146K ﹤0.01%
148,653
+2,815
IOVA icon
1105
Iovance Biotherapeutics
IOVA
$1.43B
$128K ﹤0.01%
46,842
ANIK icon
1106
Anika Therapeutics
ANIK
$204M
$121K ﹤0.01%
12,635
-33,208
OSUR icon
1107
OraSure Technologies
OSUR
$205M
$117K ﹤0.01%
48,409
RBBN icon
1108
Ribbon Communications
RBBN
$486M
$116K ﹤0.01%
40,355
-10,288
CVGI icon
1109
Commercial Vehicle Group
CVGI
$143M
$115K ﹤0.01%
79,629
-590
RCKT icon
1110
Rocket Pharmaceuticals
RCKT
$388M
$114K ﹤0.01%
32,515
-3,301
TBI
1111
Trueblue
TBI
$140M
$110K ﹤0.01%
24,231
-10,381
HBIO icon
1112
Harvard Bioscience
HBIO
$29.7M
$93.1K ﹤0.01%
13,922
DHX icon
1113
DHI Group
DHX
$121M
$70.3K ﹤0.01%
45,364
+12,110
UFI icon
1114
UNIFI
UFI
$67.6M
$67.9K ﹤0.01%
19,390
VYGR icon
1115
Voyager Therapeutics
VYGR
$232M
$64.4K ﹤0.01%
+16,381
INVE icon
1116
Identive
INVE
$101M
$47.3K ﹤0.01%
12,328
-33,157
SPRO icon
1117
Spero Therapeutics
SPRO
$160M
$43.4K ﹤0.01%
18,636
-18,357
CULP icon
1118
Culp Inc
CULP
$39M
$40.9K ﹤0.01%
11,500
AKBA icon
1119
Akebia Therapeutics
AKBA
$378M
$40K ﹤0.01%
24,872
-401,894
NDLS icon
1120
Noodles & Co
NDLS
$59.6M
$31.5K ﹤0.01%
5,579
+3,008
UVSP icon
1121
Univest Financial
UVSP
$1.06B
– –
-30,251
VICR icon
1122
Vicor
VICR
$12.2B
– –
-40,348
WABC icon
1123
Westamerica Bancorp
WABC
$1.29B
– –
-116,643
WBS icon
1124
Webster Financial
WBS
$11.6B
– –
-358,294
ABUS icon
1125
Arbutus Biopharma
ABUS
$823M
– –
-26,702
43 44
45
46 47